Pharma Capital
Showing 40 of 63
Name Market Market Cap Share Price Daily Share Movement
abzena-logo.png Abzena plc AIM £71.56m £0.34 -2.90% ico_glass.png
ahz[LOGO]200x100.jpg Admedus Ltd ASX £48.48m £0.19 0.00% ico_glass.png
Advanced-Oncotherapy-logo.png Advanced Oncotherapy AIM £21.13m £0.29 -8.06% ico_glass.png
akers.png Akers Biosciences, Inc. AIM £10.18m £1.15 -11.54% ico_glass.png
allergytherap.gif Allergy Therapeutics plc AIM £165.16m £0.28 2.02% ico_glass.png
Alliance-logo.png Alliance Pharma plc AIM £228.03m £0.48 -2.07% ico_glass.png
amryt-pharma.jpg Amryt Pharmaceuticals AIM £45.83m £0.22 0.00% ico_glass.png
angle-logo.png ANGLE plc AIM £39.65m £0.53 0.95% ico_glass.png
ado[LOGO]200x100.jpg Anteo Diagnostics ASX £21.91m £0.02 -2.94% ico_glass.png
avacta.png Avacta Group Plc AIM £60.19m £0.88 7.98% ico_glass.png
c4x.png C4X Discovery Holdings plc AIM £41.30m £0.91 0.00% ico_glass.png
cdy[LOGO]200x100.jpg Cellmid ASX £18.17m £0.02 0.00% ico_glass.png
Circadian.png Circadian Technologies ASX £- £- 0.00% ico_glass.png
clinigen-logo.png Clinigen Group PLC AIM £979.50m £8.51 1.25% ico_glass.png
collagen_solutions.png Collagen Solutions PLC AIM £19.46m £0.06 0.00% ico_glass.png
cmp[LOGO]200x100.jpg Compumedics ASX £48.75m £0.28 0.00% ico_glass.png
concepta.png Concepta AIM £18.09m £0.17 4.76% ico_glass.png
constellation-logo.png Constellation Healthcare Technologies, Inc. AIM £- £- - ico_glass.png
Cynata.png Cynata Therapeutics ASX £24.78m £0.28 -2.08% ico_glass.png
deltex-logo.png Deltex Medical Group plc AIM £11.87m £0.04 0.00% ico_glass.png
Dimerix-logo-200.png Dimerix ASX £7.80m £0.00 0.00% ico_glass.png
E--therapeutics-logo.png e-Therapeutics plc AIM £22.15m £0.08 1.54% ico_glass.png
Ergomed-logo.png Ergomed Plc AIM £79.39m £1.96 -1.26% ico_glass.png
fr.png Faron Pharmaceuticals Oy AIM £191.83m £6.92 7.65% ico_glass.png
FuturaMedical-Logo-1row-RGB.jpg Futura Medical plc. AIM £60.68m £0.50 -1.37% ico_glass.png
genedrive_logo.png Genedrive PLC AIM £8.13m £0.43 2.35% ico_glass.png
HealthLinx.png HealthLinx Limited ASX £- £- 0.00% ico_glass.png
Horizon-logo.2.png Horizon Discovery Group PLC AIM £192.52m £2.07 -1.19% ico_glass.png
imm.gif ImmuPharma PLC AIM £72.23m £0.55 2.83% ico_glass.png
iSonea.jpg iSonea Limited ASX £- £- 0.00% ico_glass.png
m_pharma_5739c0416b400.png M Pharmaceutical CSE £3.17m £0.03 0.00% ico_glass.png
MaxCyte.gif MaxCyte AIM £149.90m £2.95 4.42% ico_glass.png
Midatech_pharma.png Midatech Pharma Plc AIM £57.22m £1.18 0.00% ico_glass.png
motif-bio-logo-2.png Motif Bio Plc AIM £75.91m £0.39 -3.73% ico_glass.png
nanobiotix_logo.png Nanobiotix SA EPA £- £- - ico_glass.png
neph.png NephroGenex NASDAQ £- £- - ico_glass.png
netscientific-logo.png Netscientific PLC AIM £28.42m £0.56 -0.63% ico_glass.png
au_novogen__120x60.jpg Novogen ASX £13.58m £0.03 -2.04% ico_glass.png
optibiotix-logo-2.png OptiBiotix Health plc AIM £55.02m £0.70 -3.71% ico_glass.png
par[LOGO]200x100.jpg Paradigm Biopharmaceuticals ASX £30.31m £0.30 -5.56% ico_glass.png

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.